KAKhalid Awad Al-Kubaisi

Khalid Awad Al-Kubaisi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khalid Awad Al-Kubaisi has a total of 148 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gut Dysbiosis at the Intersection of Depression and Addiction: A Microbiota–Gut–Brain–Reward Framework and Digital Precision Behavioural Health Agenda for the United Arab Emirates

    by Hossam Ismail, Aisling Joan Oslizlok, Eric Lott, Felix Blaine, David Forbes, Amal Ammar, Renz Ocampo, Syed Javaid, Hayder Ameer Jabor, Nafi Alonaizi, et al.

    Background The microbiota–gut–brain axis provides an emerging framework for understanding neuropsychiatric disorders. Depression and addiction, despite substantial comorbidity, are frequently investigated separately. This review examines whether gut dysbiosis contributes to vulnerability, symptom persistence and recovery through shared inflammatory, endocrine, metabolic and reward-related mechanisms. Methods A structured narrative review was conducted using PubMed/MEDLINE, Scopus, Web of Science and PsycINFO, supplemented by citation searching. Priority was given to systematic reviews, meta-analyses, human cohorts, randomised trials and mechanistic studies. Evidence was evaluated for methodological quality, confounding, replication, biological plausibility and clinical relevance. Results Convergent evidence implicates altered short-chain fatty acid production, intestinal barrier dysfunction, dysregulated tryptophan–kynurenine metabolism, systemic inflammation, hypothalamic–pituitary–adrenal-axis disturbance and altered affective and reward signalling. Human evidence is strongest for major depressive disorder and alcohol use disorder, whereas evidence involving opioids, psychostimulants, cannabis and polysubstance use remains comparatively limited. Dietary interventions, probiotics, prebiotics, synbiotics and faecal microbiota transplantation demonstrate preliminary therapeutic potential. However, methodological heterogeneity, uncertain causality, limited replication and insufficient evidence of sustained benefit prevent routine clinical recommendation. Digital phenotyping, wearable technologies and artificial intelligence may facilitate integration of microbial, metabolic, behavioural and longitudinal clinical information, although prospective validation and demonstrated clinical utility remain limited. Conclusions The proposed Microbiota–Gut–Brain–Reward framework conceptualises dysbiosis as a potentially modifiable contributor rather than an independent cause of depression or addiction. Clinical translation requires longitudinal multi-omic research, harmonised methodologies, mechanistically informed trials and integration with established pharmacological, psychological and social interventions. Digitally enabled precision approaches may support personalised recovery monitoring, provided interpretability, privacy, equity and clinical governance are prioritised. The United Arab Emirates offers opportunities for culturally responsive translational research, although implementation must remain evidence-driven, ethically governed and subject to rigorous prospective evaluation before clinical adoption.

  • Open Access

    Effects of pharmacists’ involvement in pharmacogenomics implementation on patient outcomes: a scoping review

    by Nadia Al Mazrouei, Khalid Awad Al-Kubaisi, Karem H. Alzoubi, Ahmed Alhusban, Richard Mottershead, Moh'D. Ahmad Shara, Manal Mohammed Al Sharawy, Margaret Stevenson

  • The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis

    by Derar H. Abdel-Qader, Nada K. Abdelsattar, Abdullah Albassam, Khalid Awad Al-Kubais, Esra’ Taybeh, Nadia Al Mazrouei, Rana Ibrahim, Osama Mohamed Ibrahim, Taha Abd-ElSalam Ashraf Taha

    Objective This review aimed to assess the efficacy and safety of letrozole, administered either as monotherapy or combined with methotrexate, for the treatment of ectopic pregnancy (EP). Methods Following established guidelines (PRISMA), a systematic review and meta-analysis was conducted. Major online research databases (Web of Science, PubMed, Scopus, and Cochrane Library) were searched for studies comparing letrozole to methotrexate in women diagnosed with EP via ultrasound, from the earliest available records up to November 5, 2024. The combined results were analyzed using risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI). The quality of the included studies was evaluated using ROB-2 and ROBINS-I tools. Results Eight studies (five randomized and three non-randomized trials) involving 548 participants were included. Letrozole monotherapy achieved a higher treatment success rate compared to methotrexate (6 studies, 376 patients, RR 1.10, 95% CI [1.01, 1.20], p = 0.03). Combining letrozole with methotrexate showed comparable success rates to methotrexate alone (2 studies, 161 patients, RR 1.09, 95% CI [0.96, 1.23], p = 0.17). On day 4, β-human chorionic gonadotropin (β-hCG) levels decreased faster in both the letrozole monotherapy (5 studies, 291 patients, MD -131.15 mIU/mL, 95% CI [-220.77, -41.52], p = 0.004) and combination groups (2 studies, 136 patients, MD -188.79 mIU/mL, 95% CI [-242.07, -135.52], p < 0.00001). Letrozole monotherapy resulted in a smaller reduction in platelet count (2 studies, 76 patients, MD 81.61 × 10³/µL, 95% CI [40.11, 123.10], p = 0.0001) and better-preserved liver enzymes, such as ALT (3 studies, 76 patients, MD -21.27 IU/L, 95% CI [-24.42, -18.12], p < 0.00001). No differences were noted in anti-Müllerian hormone (AMH) levels (2 studies, 39 patients, MD -0.01 ng/mL, 95% CI [-0.40, 0.38], p = 0.97). Conclusions Letrozole, especially when used as the only treatment, may be a more effective and potentially safer alternative to methotrexate for medically treating EP. However, larger, higher-quality research studies are necessary to confirm these findings and to determine the best way to use letrozole.

  • Open Access

    Pharmacogenomics knowledge and implementation readiness among community pharmacists in Jordan: A national cross-sectional study

    by Khalid Awad Al-Kubaisi, Derar H. Abdel-Qader, Nadia Al Mazrouei, Rana Ibrahim, Ahmed Alhusban

    Pharmacogenomics (PGx) offers a powerful strategy to improve medication safety and efficacy, yet its integration into community pharmacy practice remains limited. While an “attitude-knowledge gap” is known to exist globally, limited national data exist concerning PGx readiness among community pharmacists in Jordan. This study aimed to (i) quantify Clinical Pharmacogenetics Implementation Consortium (CPIC)-aligned PGx knowledge and characterize attitudes; (ii) assess implementation readiness across organizational, leadership, and structural dimensions; (iii) map perceived barriers; and (iv) identify independent predictors of knowledge, attitudes, and readiness. A national, cross-sectional survey was conducted using a proportionate stratified random sampling method. A content-validated and reliability-tested electronic questionnaire was distributed to community pharmacists across Jordan’s three administrative regions. The instrument assessed demographics, CPIC-aligned knowledge, attitudes and perceived barriers on five-point Likert scales, and theory-informed implementation readiness. Data were analyzed using descriptive statistics, bivariate tests, and multiple linear regression. A total of 347 community pharmacists completed the survey. A vast majority (83.0%) reported no prior formal PGx training. Knowledge of practical PGx was low, with a mean score of 5.54 ± 2.12 out of 10. Attitudes were neutral (mean = 3.49 ± 0.26), while perceived barriers were rated as significant (mean severity = 3.45 ± 0.30), with privacy concerns being the highest-rated challenge (mean = 3.65 ± 0.78). Total implementation readiness was moderate (mean = 3.34 ± 0.25), with organizational readiness (mean = 3.39) rated higher than structural readiness (mean = 3.21) or leadership support (mean = 3.27). Bivariate analyses revealed few significant associations, and crucially, multiple linear regression models showed that no demographic or practice characteristics within the variables tested were significant independent predictors of knowledge or readiness. Jordanian community pharmacists demonstrated a significant gap between their positive attitudes towards PGx and the practical knowledge and systemic support required for clinical implementation. The findings revealed that the identified deficits in knowledge and readiness were widespread across all surveyed subgroups, not concentrated in specific demographic or professional subgroups. Translating the existing positive sentiment into routine clinical practice urgently requires a nationwide, standardized educational strategy coupled with the development of systemic enablers, including reimbursement pathways, integrated clinical workflows, and explicit leadership support.

  • Open Access

    Digital health literacy as a predictor of patient safety culture: evidence from a multi-centre study of Jordanian nurses

    by Nadia Al Mazrouei, Khalid Awad Al-Kubaisi, Derar H. Abdel-Qader, Abduelmula R. Abduelkarem, Karem H. Alzoubi, Moh'D. Ahmad Shara, Richard Mottershead

    The digitalisation of healthcare requires nurses to possess strong Digital Health Literacy (DHL) to ensure patient safety. This study aimed to evaluate the relationship between DHL and perceptions of PSC among registered nurses in Jordan and to identify the demographic and professional factors associated with varying levels of DHL. A multi-center, cross-sectional survey was conducted from July to September 2025 across five public, private, and university-affiliated hospitals in Jordan. A sample of 500 registered nurses was recruited using stratified random sampling. Data were collected using a validated, seven-part composite questionnaire. Data were analyzed using descriptive statistics, reliability analysis (Cronbach’s alpha), and structural equation modelling. The results confirmed the study's primary hypothesis, revealing a significant and strong positive predictive relationship between DHL and PSC (β = 0.42, p < 0.001), with DHL explaining 28.1% of the variance in PSC. Nurses reported moderately high DHL overall (M = 3.28), with strengths in operational skills but lower confidence in evaluating information reliability. Perceptions of patient safety culture were positive (M = 3.71), with Teamwork Climate rated highest (M = 4.21) and Perceptions of Management lowest (M = 3.34). Significant disparities in DHL were found; higher levels of education (p < .001) and working in a university-affiliated hospital (p = 0.001) were associated with higher competency. Notably, no significant differences were observed based on age or years of experience. Lack of adequate training and insufficient time were identified as the primary organisational barriers to technology use. Digital health literacy was significantly associated with better patient safety culture among Jordanian nurses, driven more by organisational and educational factors than generational stereotypes. To realise the safety benefits of digital health investments, institutions should strengthen nurses’ digital and critical appraisal skills and remove organisational barriers.


  • Open Access

    Community pharmacists’ perceptions and practices regarding medication home delivery service: a cross-sectional study in the United Arab Emirates

    by Hala Alobaidi, Feras Jirjees, Mohanad Odeh, Amna M Othman, Zelal Kharaba, Abderraouf Haitamar, Abdulrahman Alzyoud, Yahya H Dallal Bashi, Mamoon A Aldeyab, Ahmad Al-Azayzih, et al.

    Objectives: The healthcare sector is evolving with a growing emphasis on remote services and patient-centred care. Medication Home Delivery (MHD) service has become essential in enhancing accessibility, allowing patients to receive medications at home. This study evaluates the perceptions, practices, challenges, and benefits of the MHD service among community pharmacists in the United Arab Emirates (UAE), providing insights for policy and practice improvements. Methods: A cross-sectional survey was conducted among 403 licensed community pharmacists in the UAE. Participants completed a self-administered questionnaire assessing their awareness, perceptions, and experiences with the MHD service. Data analysis included descriptive statistics and logistic regression to identify factors influencing service provision. Key findings: Among respondents, 83.6% offered the MHD service, primarily through online platforms. Main factors influencing service provision included participants’ age, employment status, pharmacy type, and location (P < .05). Pharmacists raised concerns about patient counseling quality, communication, and medication security, highlighting the need for training to improve regulatory adherence. Major challenges included staffing shortages (51.6%), increased workload (36.5%), and limited time for patient counseling (41.2%). Despite these barriers, most pharmacists recognized MHD’s benefits in enhancing pharmacy efficiency (87.2%) and patient convenience (51.3%), particularly for elderly and disabled individuals (86.9%). Those not offering the MHD service cited unclear policies (24.2%) and logistical constraints as primary barriers (24.2%). Conclusions: This study underscores both the opportunities and operational challenges of the MHD service in the UAE community pharmacies. Optimizing the service requires policy refinements, improved logistical frameworks, and targeted training programs to enhance service delivery, regulatory compliance, and patient care outcomes.

  • Open Access

    Assessing Knowledge, Attitudes, and Practices (KAP) related to green pharmacy among community and hospital pharmacists in Jordan

    by Derar H. Abdel-Qader, Khalid Awad Al-Kubaisi, Nadia Al Mazrouei, Rana Ibrahim, Ahmed Alhusban

    Background: Pharmaceutical pollution is a growing global concern with serious implications for ecosystems, human health, and water quality. In Jordan, this issue is amplified by weak enforcement of disposal regulations and low public awareness, with studies showing as few as 10% of residents return unused medicines to pharmacies. As trusted medication experts, pharmacists are uniquely positioned to advocate for and implement green pharmacy practices, the integration of environmental stewardship across the pharmaceutical lifecycle. However, the extent to which Jordanian pharmacists are equipped and enabled to fulfill this role has not been systematically assessed. Objective: This study aimed to provide the first comprehensive assessment of the knowledge, attitudes, and practices (KAP) of both hospital and community pharmacists in Jordan regarding green pharmacy and to identify key predictors of their engagement. Methods: This cross-sectional survey was conducted over a one-month period among 380 licensed pharmacists practicing in community and hospital settings across Jordan’s three administrative regions. A validated, self-administered questionnaire was used to assess KAP, perceived barriers, and recommendations. The primary outcomes were scores for knowledge, attitudes, and practices. Descriptive statistics were used to summarize KAP levels, and three separate multivariable logistic regression models were developed to identify predictors of Good Knowledge (score ≥ 80%), Positive Attitude (score > 27), and Good Practice (score ≥ 23). Results: The study identified a significant attitude-practice gap. While pharmacists demonstrated overwhelmingly positive attitudes (mean score 4.4 ± 0.7), this did not translate into consistent practice (mean score 2.9 ± 1.2), particularly for actions requiring systemic support. Multivariable logistic regression analyses revealed that prior training was a consistent and powerful predictor across all domains. Good Knowledge (score ≥ 80%) was most strongly predicted by prior training (aOR = 5.21) and practicing in a chain pharmacy (aOR = 1.60). Highly Positive Attitude (mean score > 4.0) was significantly predicted by younger age (< 35 years; aOR = 1.95) and prior training (aOR = 1.80). Critically, Good Practice (mean score ≥ 3.5) was not predicted by attitude, but by structural and educational factors: prior training (aOR = 3.85), practicing in a chain pharmacy (aOR = 2.01), and a hospital setting (aOR = 1.75). Conclusion: This study, the first to assess comprehensively KAP on this topic in Jordan, underscored that the primary barriers to green pharmacy were systemic, not a lack of professional will. The findings provided an evidence-based roadmap, highlighting the urgent need for national guidelines, targeted training, and supportive infrastructure to empower pharmacists to translate their positive attitudes into meaningful environmental stewardship.


  • Open Access

    The impact of artificial intelligence on the prescribing, selection, resistance, and stewardship of antimicrobials: a scoping review

    by Nadia Al Mazrouei, Asim Ahmed Elnour, Safaa Badi, Fahad T. Alsulami, Ali Awadallah Mohamed Saeed, Khalid Awad Al-Kubaisi, Vineetha Menon, Israa Yousif Khidir, Marwan Ismail, Maha Mahagoub Osman Mahagoub, et al.

    Antimicrobial selection, prescribing, and resistance are global health issues resulting from the overuse and misuse of antimicrobials in the healthcare and


  • Open Access

    Assessing community pharmacists’ responses to pregnancy-related nausea and vomiting: A national simulated patient study in Jordan

    by Khalid Al Kubaisi, Derar H. Abdel-Qader, Nadia Al Mazrouei, Abduelmula R. Abduelkarem, Yahya H. Dallal Bashi Dallal Bashi, Moh’d Ahmad Shara

    Background and aim: Nausea and vomiting of pregnancy (NVP) is the most common medical condition of gestation, affecting up to 90% of women and significantly impacting their quality of life. Community pharmacists (CPs) are often the first point of contact for these women, yet there is a lack of objective data on their practice quality in Jordan. This study aimed to conduct the first national, simulated patient study to assess objectively the assessment, management, counseling, satisfaction and predictors of appropriate practice among Jordanian community CPs when managing NVP. Materials and methods: A national, cross-sectional study using a simulated patient methodology was conducted in 380 community pharmacies, selected via proportionate stratified random sampling. Two validated scenarios (mild NVP and severe NVP with red flags) were used. A validated structured data collection form documented CPs ‘ assessment, management, counseling, and patient satisfaction. Multivariable logistic regression was used to identify independent predictors of “Appropriate Practice.” All data were analysed using SPSS (V28.0). Results: A significant gap between guideline-recommended care and actual practice was evident, particularly in high-risk situations. While most CPs (84.2%) initiated symptom inquiry, crucial assessment of red flags in the severe NVP scenario was dangerously low (e.g., inquiry about dehydration, 21.1%). This assessment failure translated directly to practice: only 56.8% of CPs correctly referred the high-risk patient, while 43.2% inappropriately sold an over-the-counter medication, delaying necessary medical care. Counseling on medication safety was consistently poor, with only 29.9% of CPs discussing potential side effects. Despite these clinical deficiencies, the overall patient satisfaction was high, appearing to be driven more by interpersonal skills than clinical accuracy. Multivariable analysis revealed that appropriate practice was independently predicted by prior maternal health training (aOR = 3.48, p < 0.001) and being a female pharmacist (aOR = 2.01, p = 0.009). Conversely, a high pharmacy workload was a significant independent barrier, reducing the odds of providing appropriate care by 50% (aOR = 0.50, p = 0.018). Conclusion: Jordanian community CPs are a critical but currently underperforming resource in maternal care. The prevalent gaps in clinical assessment and referral for severe NVP represent a significant patient safety risk. A one-size-fits-all approach to quality improvement is unlikely to succeed. Instead, a dual-pronged strategy is essential: (1) national professional pharmacy bodies must mandate targeted continuing professional development in maternal health, focusing on risk assessment and referral protocols; and (2) health policymakers and community pharmacy owners must address systemic barriers, particularly the detrimental impact of high workload on the delivery of safe and effective patient care.